Swiss National Bank Dynavax Technologies Corp Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Swiss National Bank holds 244,078 shares of DVAX stock, worth $3.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

244,078

Previous 244,078 -0.0%

Holding current value

$3.15 Million

Previous $2.74 Million 0.77%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$10.73 - $12.58 $16,095 - $18,870	1,500 Added 0.62%	244,078 $2.74 Million
Q1 2024 May 07, 2024	SELL	$11.7 - $14.98 $132,210 - $169,274	-11,300 Reduced 4.45%	242,578 $3.01 Million
Q4 2023 Feb 06, 2024	SELL	$13.09 - $14.98 $373,065 - $426,930	-28,500 Reduced 10.09%	253,878 $3.55 Million
Q3 2023 Nov 08, 2023	BUY	$12.64 - $14.99 $34,128 - $40,473	2,700 Added 0.97%	282,378 $4.17 Million
Q2 2023 Aug 09, 2023	BUY	$9.85 - $13.17 $178,285 - $238,377	18,100 Added 6.92%	279,678 $3.61 Million
Q1 2023 May 10, 2023	SELL	$9.44 - $11.88 $269,040 - $338,580	-28,500 Reduced 9.82%	261,578 $2.57 Million
Q4 2022 Feb 08, 2023	BUY	$10.27 - $13.29 $56,485 - $73,095	5,500 Added 1.93%	290,078 $3.09 Million
Q3 2022 Nov 09, 2022	BUY	$9.93 - $17.44 $160,866 - $282,528	16,200 Added 6.04%	284,578 $2.97 Million
Q2 2022 Aug 09, 2022	SELL	$7.45 - $12.83 $113,240 - $195,016	-15,200 Reduced 5.36%	268,378 $3.38 Million
Q1 2022 May 09, 2022	BUY	$9.75 - $14.44 $296,400 - $438,976	30,400 Added 12.01%	283,578 $3.07 Million
Q3 2021 Nov 08, 2021	BUY	$9.16 - $19.83 $32,060 - $69,405	3,500 Added 1.4%	253,178 $4.86 Million
Q2 2021 Aug 06, 2021	BUY	$7.25 - $10.99 $167,475 - $253,869	23,100 Added 10.2%	249,678 $2.46 Million
Q1 2021 May 07, 2021	BUY	$4.57 - $11.18 $16,909 - $41,366	3,700 Added 1.66%	226,578 $2.23 Million
Q4 2020 Feb 05, 2021	BUY	$3.73 - $5.6 $23,499 - $35,280	6,300 Added 2.91%	222,878 $992,000
Q3 2020 Nov 09, 2020	BUY	$4.32 - $11.7 $13,824 - $37,440	3,200 Added 1.5%	216,578 $936,000
Q2 2020 Aug 05, 2020	BUY	$2.94 - $9.1 $156,114 - $483,210	53,100 Added 33.13%	213,378 $1.89 Million
Q4 2019 Feb 06, 2020	BUY	$3.46 - $6.93 $11,764 - $23,562	3,400 Added 2.17%	160,278 $917,000
Q3 2019 Nov 12, 2019	BUY	$2.69 - $4.85 $101,682 - $183,330	37,800 Added 31.74%	156,878 $561,000
Q2 2019 Aug 02, 2019	BUY	$3.65 - $7.89 $17,520 - $37,872	4,800 Added 4.2%	119,078 $475,000
Q1 2019 May 10, 2019	BUY	$7.08 - $12.09 $25,488 - $43,524	3,600 Added 3.25%	114,278 $835,000
Q4 2018 Feb 13, 2019	BUY	$8.14 - $13.28 $52,910 - $86,320	6,500 Added 6.24%	110,678 $1.01 Million
Q1 2018 May 04, 2018	BUY	$14.65 - $19.9 $62,995 - $85,570	4,300 Added 4.31%	104,178 $2.07 Million
Q3 2017 Nov 03, 2017	BUY	$15.2 - $21.5 $1.52 Million - $2.15 Million	99,878	99,878 $2.15 Million

Others Institutions Holding DVAX

# of Institutions

276

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.63B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Dynavax Technologies Corp Transaction History